You are currently viewing a new version of our website. To view the old version click .

Cancers, Volume 14, Issue 21

November-1 2022 - 301 articles

Cover Story: Complementary and alternative medicine (CAM) therapies include a wide range of procedures and products that are often used by cancer patients to directly combat cancer and protect normal cells from the toxic effects of conventional therapies. Most often, their use is self-prescribed, based on a collection of scattered information from websites and advice from relatives or friends, possibly leading to unexpected toxicities and a reduction in the efficacy of cancer therapy. Despite claims of promising and potential benefits made by prescribers, many CAMs lack clear scientific evidence of their safety and efficacy. Given the widespread use of CAM, in this review we focused on the most important known data on the interaction risk between anticancer drugs and CAMs in accordance with the meaning of integrative medicine, providing a practical guide for caregivers and patients. View this paper
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (301)

  • Review
  • Open Access
9 Citations
6,768 Views
28 Pages

Ewing Sarcoma Meets Epigenetics, Immunology and Nanomedicine: Moving Forward into Novel Therapeutic Strategies

  • Sara Sánchez-Molina,
  • Elisabet Figuerola-Bou,
  • Víctor Sánchez-Margalet,
  • Luis de la Cruz-Merino,
  • Jaume Mora,
  • Enrique de Álava Casado,
  • Daniel José García-Domínguez and
  • Lourdes Hontecillas-Prieto

7 November 2022

Ewing Sarcoma (EWS) is an aggressive bone and soft tissue tumor that mainly affects children, adolescents, and young adults. The standard therapy, including chemotherapy, surgery, and radiotherapy, has substantially improved the survival of EWS patie...

  • Review
  • Open Access
21 Citations
3,269 Views
22 Pages

Histone Deacetylase Functions in Gastric Cancer: Therapeutic Target?

  • Amandine Badie,
  • Christian Gaiddon and
  • Georg Mellitzer

7 November 2022

Gastric cancer (GC) is one of the most aggressive cancers. Therapeutic treatments are based on surgery combined with chemotherapy using a combination of platinum-based agents. However, at metastatic stages of the disease, survival is extremely low du...

  • Review
  • Open Access
4 Citations
3,789 Views
13 Pages

Aptamers, a New Therapeutic Opportunity for the Treatment of Multiple Myeloma

  • Ane Amundarain,
  • Fernando Pastor,
  • Felipe Prósper and
  • Xabier Agirre

7 November 2022

Multiple Myeloma (MM) remains an incurable disease due to high relapse rates and fast development of drug resistances. The introduction of monoclonal antibodies (mAb) has caused a paradigm shift in MM treatment, paving the way for targeted approaches...

  • Systematic Review
  • Open Access
37 Citations
4,022 Views
12 Pages

The Effects of Patient-Reported Outcome Screening on the Survival of People with Cancer: A Systematic Review and Meta-Analysis

  • Caterina Caminiti,
  • Giuseppe Maglietta,
  • Francesca Diodati,
  • Matteo Puntoni,
  • Barbara Marcomini,
  • Silvia Lazzarelli,
  • Carmine Pinto and
  • Francesco Perrone

7 November 2022

This study examined the effects of the routine assessment of patient-reported outcomes (PROs) on the overall survival of adult patients with cancer. We included clinical trials and observational studies with a control group that compared PRO monitori...

  • Article
  • Open Access
7 Citations
2,525 Views
9 Pages

Reinduction of Hedgehog Inhibitors after Checkpoint Inhibition in Advanced Basal Cell Carcinoma: A Series of 12 Patients

  • Viola K. DeTemple,
  • Jessica C. Hassel,
  • Michael M. Sachse,
  • Imke Grimmelmann,
  • Ulrike Leiter,
  • Christoffer Gebhardt,
  • Julia Eckardt,
  • Claudia Pföhler,
  • Yenny Angela and
  • Hanna Hübbe
  • + 1 author

7 November 2022

For patients with advanced basal cell carcinoma (aBCC) first-line treatment with hedgehog inhibitors (HHIs) and second-line treatment with PD1 inhibitors (PD1i) is available, offering combination and sequencing options. Here, we focus on the efficacy...

  • Review
  • Open Access
11 Citations
9,554 Views
18 Pages

Post-Neoadjuvant Treatment Strategies for Patients with Early Breast Cancer

  • Elisa Agostinetto,
  • Flavia Jacobs,
  • Véronique Debien,
  • Alex De Caluwé,
  • Catalin-Florin Pop,
  • Xavier Catteau,
  • Philippe Aftimos,
  • Evandro de Azambuja and
  • Laurence Buisseret

7 November 2022

Pre-surgical treatments in patients with early breast cancer allows a direct estimation of treatment efficacy, by comparing the tumor and the treatment. Patients who achieve a pathological complete response at surgery have a better prognosis, with lo...

  • Review
  • Open Access
34 Citations
7,871 Views
26 Pages

7 November 2022

Hepatocellular carcinoma (HCC) is a major cause of cancer death worldwide due to its high rates of tumor recurrence and metastasis. Aberrant Wnt/β-catenin signaling has been shown to play a significant role in HCC development, progression and cl...

  • Systematic Review
  • Open Access
11 Citations
5,297 Views
16 Pages

7 November 2022

Awake craniotomy with direct electrical stimulation (DES) is the standard treatment for patients with gliomas in eloquent areas. Even though language is monitored carefully during surgery, many patients suffer from postoperative aphasia, with negativ...

  • Article
  • Open Access
2 Citations
2,317 Views
18 Pages

The Glasgow Prognostic Score Predicts Survival Outcomes in Neuroendocrine Neoplasms of the Gastro–Entero–Pancreatic (GEP-NEN) System

  • Niklas Gebauer,
  • Maria Ziehm,
  • Judith Gebauer,
  • Armin Riecke,
  • Sebastian Meyhöfer,
  • Birte Kulemann,
  • Nikolas von Bubnoff,
  • Konrad Steinestel,
  • Arthur Bauer and
  • Hanno M. Witte

7 November 2022

Background: Across a variety of solid tumors, prognostic implications of nutritional and inflammation-based risk scores have been identified as a complementary resource of risk stratification. Methods: In this retrospective study, we performed a comp...

  • Systematic Review
  • Open Access
7 Citations
3,598 Views
19 Pages

Anastomotic Leak in Ovarian Cancer Cytoreduction Surgery: A Systematic Review and Meta-Analysis

  • Massimiliano Fornasiero,
  • Georgios Geropoulos,
  • Konstantinos S. Kechagias,
  • Kyriakos Psarras,
  • Konstantinos Katsikas Triantafyllidis,
  • Panagiotis Giannos,
  • Georgios Koimtzis,
  • Nikoletta A. Petrou,
  • James Lucocq and
  • Christos Kontovounisios
  • + 1 author

7 November 2022

Introduction: Anastomotic leaks (AL) following ovarian cytoreduction surgery could be detrimental, leading to significant delays in commencing adjuvant chemotherapy, prolonged hospital stays and increased morbidity. The aim of this study was to inves...

of 31

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Cancers - ISSN 2072-6694